Genmab — Maj 2021

[peter12]

Bulder jeg tror CR er et RECIST kriterie og CMR et PET-CT men ellers ved jeg ikke

[Bulder]

Nederst i denne artikel står at recist-kriterier ikke kan bruges til lymfomer https://pri.rn.dk/Sider/19237.aspx

[E_L]

here is your release @Bulder . I was told they made it specially for you. https://ir.genmab.com/news-releases/news-release-details/genmab-announces-janssen-has-received-positive-chmp-opinion

[Bulder]

In the "old" days you could have these messages in your mail-box. What happenned to that arrangement?

[Helge_LarsenPI-redaktør]

Just a moment...

(www.proinvestor.com)

[E_L]

15:23 for me, but it had to travel further all the way to NL!

[Bulder]

Hvor har I meldt jer til? Jeg fik dem også førhen. Men pludselig holdt det op.

[E_L]

you did ask Jan some very difficult questions in the Q&A Bulder ; was that when the emails stopped ?

[Bulder]

Det lyder sandsynligt Mails er ikke for fattigrøve

[deleted-user]

15:10 - jeg må sidde tæt på serveren

[JørgenVarnæs]

Fattigrøve kan begynde her - https://ir.genmab.com/email-alert-subscription#content

[Bulder]

Tak JV. Jeg har ledt og ledt efter det.

[E_L]

Did we not assume roughly 10% market size for amyloidosis vs MM?

[deleted-user]

Pokkers. Var det ikke sidste år? God pinseferie til jer alle, når I kommer så langt,

[E_L]

the press release reads 'It is estimated that in 2019 there were 4,388 diagnosed incident cases of AL amyloidosis in the five major European markets.2'

[E_L]

So, lets assume easily >5.000 for whole western europe

[E_L]

'Approximately 18,114 new patients were diagnosed with multiple myeloma and approximately 11,063 people died from the disease in the Western Europe in 2020.'

[E_L]

that is not 10%...

[Bulder]

In my notes I have MM 27,8 bn $ and Amy 6,7 bn $.

[E_L]

that is much closer in %